U.S., July 4 -- ClinicalTrials.gov registry received information related to the study (NCT07048886) titled 'Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)' on June 15.
Brief Summary: The primary objective of this study is to determine if the addition of Rocklatan post-Hydrus will provide additional intraocular pressure lowering.
Study Start Date: July 15
Study Type: INTERVENTIONAL
Condition:
Primary Open Angle Glaucoma
Intervention:
DRUG: Rocklatan (netarsudil 0.02% and latanoprost 0.005%)
Additional intraocular eye pressure lowering post-Hydrus
DRUG: Systane
Placebo Comparator (artificial tears)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Center for Sight Las Vegas
Published by HT Digita...